Paradoxical severe decrease in serum HDL-cholesterol after treatment with a fibrate.
Olukoga
A O
AO
D001629:Bezafibrate / Q000009:adverse effects*; D008076:Cholesterol, HDL / Q000097:blood*; D006801:Humans; D000960:Hypolipidemic Agents / Q000009:adverse effects*; D009395:Nephritis, Interstitial / Q000139:chemically induced
D008076:Cholesterol, HDL; D000960:Hypolipidemic Agents; D001629:Bezafibrate